CYLD and benign prostatic hyperplasia: This finding aligns with the results of several researchers, who identified G-protein-coupled receptor-associated sorting protein 1, epigenetic DNA modifications, vitamin C, and the CYLD, JAK2, and TLR4 genotypes as important links between BPH and PCa (142–144).